Abstract: Modified ciliary neurotrophic factors and methods for their production and therapeutic use, especially in the treatment of Huntington's disease.
Type:
Grant
Filed:
May 13, 1996
Date of Patent:
June 25, 2002
Assignee:
Regeneron Pharmaceuticals, Inc.
Inventors:
Nikos Panayotatos, Keith D. Anderson, Stanley J. Wiegand, Ronald M. Lindsay